Showing results (301-310 of 406) with videos related to
Sort By:
Pageof 41
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.Neuro-Oncology|October 13, 2022
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, William C Chen, Calixto-Hope G Lucas, et al.Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.Brain Pathology (Zurich, Switzerland)|August 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumorsPieter Wesseling, David Capper, Guido Reifenberger, et al.Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2015
Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform NeurofibromaAngela C Hirbe, Sonika Dahiya, Christopher A Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastomaJiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II StudyAndrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, et al.Pageof 41